Cargando…
Depletion of ID3 enhances mesenchymal stem cells therapy by targeting BMP4 in Sjögren’s syndrome
Mesenchymal stem cell (MSCs) transplantation has been used to treat Sjögren’s syndrome (SS) based on the immunoregulatory properties of MSCs. However, the effectiveness need improving and its underlying intrinsic mechanisms remain largely unknown. Here, we show that Id3 is upregulated in bone marrow...
Autores principales: | Hu, Lei, Xu, Junji, Wu, Tingting, Fan, Zhipeng, Sun, Lingyun, Liu, Yi, Li, Yan, Zhang, Chunmei, Wang, Jingsong, Ding, Yaozhong, Wang, Songlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058624/ https://www.ncbi.nlm.nih.gov/pubmed/32139667 http://dx.doi.org/10.1038/s41419-020-2359-6 |
Ejemplares similares
-
Bone Morphogenetic Protein 4 Alleviates DSS-Induced Ulcerative Colitis Through Activating Intestinal Stem Cell by Target ID3
por: Hu, Lei, et al.
Publicado: (2021) -
BMP4 Exerts Anti-Neurogenic Effect via Inducing Id3 during Aging
por: Li, Tingting, et al.
Publicado: (2022) -
Dysfunction of metabolic activity of bone marrow mesenchymal stem cells in aged mice
por: Li, Xiaoyu, et al.
Publicado: (2022) -
Adenovirus-mediated transfer of hepatocyte growth factor gene to human dental pulp stem cells under good manufacturing practice improves their potential for periodontal regeneration in swine
por: Cao, Yu, et al.
Publicado: (2015) -
Mesenchymal Stem Cell Enhances the Function of MDSCs in Experimental Sjögren Syndrome
por: Tian, Jie, et al.
Publicado: (2020)